EUVIMEDEUVIMED entdecken
Crossref

Efficacy and safety of carteolol long-acting solution 2% compared with timolol gel-forming solution 0.5% in patients with primary open-angle glaucoma and ocular hypertension: A randomized, parallel-group, open-label phase IV study in Taiwan

Da-Wen Lu, Hsin-Yu Yao, Yi-Hao Chen, Ming-Cheng Tai

Journal of Medical Sciences · 2014

DOI: 10.4103/1011-4564.131892 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Sciences, 2014. Verfasst von Da-Wen Lu und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The purpose of this study is to compare the efficacy and safety of 2% long-acting carteolol solution with 0.5% timolol gel-forming solution added to primary treatment of 0.005% latanoprost solution in patients with primary open-angle glaucoma and ocular hypertension. Materials and Methods: After at least 4 weeks primary treatment with latanoprost, all patients received the combination therapy with either 2% long-acting carteolol or 0.5% timolol gel in addition to latanoprost for 8 weeks. We measured intraocular pressure (IOP) and evaluated systemic and local adverse events between Day 1 and Day 56.

Results

Carteolol significantly reduced the IOP from baseline (latanoprost monotherapy) by 11.0% at Day 28 and 11.2% at Day 56. Timolol also reduced IOP by 11.5% at Day 28 and 11.0% at Day 56. There was no statistically significant difference in the IOP reduction between the two groups. There was no adverse event related to the administration of these anti-glaucoma medications during the study period.

Conclusions

Both once daily carteolol and timolol medications are safe and effective treatments combined with latanoprost single therapy.

Zitieren

APA

Lu, D., Yao, H., Chen, Y., & Tai, M. (2014). Efficacy and safety of carteolol long-acting solution 2% compared with timolol gel-forming solution 0.5% in patients with primary open-angle glaucoma and ocular hypertension: A randomized, parallel-group, open-label phase IV study in Taiwan. Journal of Medical Sciences. https://doi.org/10.4103/1011-4564.131892

Vancouver

Lu D, Yao H, Chen Y, Tai M. Efficacy and safety of carteolol long-acting solution 2% compared with timolol gel-forming solution 0.5% in patients with primary open-angle glaucoma and ocular hypertension: A randomized, parallel-group, open-label phase IV study in Taiwan. Journal of Medical Sciences. 2014. doi:10.4103/1011-4564.131892

BibTeX
@article{Lu2014,
  author = {Lu, Da-Wen and Yao, Hsin-Yu and Chen, Yi-Hao and Tai, Ming-Cheng},
  title = {Efficacy and safety of carteolol long-acting solution 2% compared with timolol gel-forming solution 0.5% in patients with primary open-angle glaucoma and ocular hypertension: A randomized, parallel-group, open-label phase IV study in Taiwan},
  journal = {Journal of Medical Sciences},
  year = {2014},
  doi = {10.4103/1011-4564.131892}
}
Kostenlos starten →